Bioassay protocol metadata annotation: Proposed standards adoption

Area of Science:

• Biomedical Research
• Drug Discovery
• Data Science

Background:

• Bioassays are critical for advancing biomedical research and drug discovery.
• Increasing volumes of assay data present challenges in understanding and comparison.
• Current assay data often lacks standardization, hindering computational analysis.

Purpose of the Study:

• To introduce a standardized metadata template for pharmaceutical drug discovery assays.
• To ensure assay data adheres to the FAIR (Findable, Accessible, Interoperable, Reusable) principles.
• To facilitate the use of artificial intelligence and computational methods in drug discovery.

Main Methods:

• Development of a standardized metadata template for assay data.
• Utilization of an automated tool for annotating assay data.
• Integration of data from diverse sources like PubChem, commercial providers, and literature.

Main Results:

• A standardized metadata template for drug discovery assays has been created.
• An automated tool effectively annotates assay data to the template.
• The process improves the FAIRness of assay data from multiple sources.

Conclusions:

• Standardized assay metadata enhances data comparability and understanding for drug discovery scientists.
• Improved metadata facilitates the application of AI and computational tools for analysis and prediction.
• Enhancements in assay metadata can significantly boost productivity in therapeutic and technology development.